109 related articles for article (PubMed ID: 1999132)
1. Nuclear shape as a prognostic discriminant in colorectal carcinoma.
Mitmaker B; Begin LR; Gordon PH
Dis Colon Rectum; 1991 Mar; 34(3):249-59. PubMed ID: 1999132
[TBL] [Abstract][Full Text] [Related]
2. The value of nuclear morphometry in the management of patients with colorectal polyps that contain invasive adenocarcinoma.
Mitmaker B; Kyzer S; Begin LR; Gordon PH
J Surg Oncol; 1992 Sep; 51(1):42-6. PubMed ID: 1518294
[TBL] [Abstract][Full Text] [Related]
3. Assessment of colorectal cancer prognosis through nuclear morphometry.
Eynard HG; Soria EA; Cuestas E; Rovasio RA; Eynard AR
J Surg Res; 2009 Jun; 154(2):345-8. PubMed ID: 18708194
[TBL] [Abstract][Full Text] [Related]
4. Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma.
Ikeguchi M; Sakatani T; Endo K; Makino M; Kaibara N
Cancer; 1999 Nov; 86(10):1944-51. PubMed ID: 10570417
[TBL] [Abstract][Full Text] [Related]
5. Absence of prognostic value of nuclear shape factor analysis in colorectal carcinoma: relevance of interobserver and intraobserver variability.
Di Fabio F; Shrier I; Bégin LR; Gordon PH
Dis Colon Rectum; 2008 Dec; 51(12):1781-5. PubMed ID: 18581174
[TBL] [Abstract][Full Text] [Related]
6. Correlation of nuclear morphometry and DNA ploidy in rectal cancer.
Heimann TM; Cohen RD; Szporn A; Gil J
Dis Colon Rectum; 1991 Jun; 34(6):449-54. PubMed ID: 2036923
[TBL] [Abstract][Full Text] [Related]
7. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
[TBL] [Abstract][Full Text] [Related]
8. Nuclear area is a prognostic determinant in advanced colorectal cancer.
Buhmeida A; Ristamäki R; Lamlum H; Bendardaf R; Heikkilä S; Collan Y; Syrjänen K; Pyrhönen S
Anticancer Res; 2005; 25(4):3083-8. PubMed ID: 16080569
[TBL] [Abstract][Full Text] [Related]
9. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
11. Comparison of classic and quantitative prognostic factors in colorectal cancer.
Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of optic morphometry in colorectal cancer].
Puente Domínguez JL
An R Acad Nac Med (Madr); 2000; 117(3):469-81; discussion 482-4. PubMed ID: 11205034
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphometry in male breast carcinoma: association with cell proliferative activity, oncogene expression, DNA content and prognosis.
Chiusa L; Margaria E; Pich A
Int J Cancer; 2000 Nov; 89(6):494-9. PubMed ID: 11102893
[TBL] [Abstract][Full Text] [Related]
15. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.
Mohler JL; Figlesthaler WM; Zhang XZ; Partin AW; Maygarden SJ
Cancer; 1994 Dec; 74(11):2996-3001. PubMed ID: 7954263
[TBL] [Abstract][Full Text] [Related]
16. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of nuclear morphometry in colorectal cancer.
Fernández-López F; Paredes-Cotoré JP; Cadarso-Suárez C; Forteza-Vila J; Puente-Domínguez JL; Potel-Lesquereux J
Dis Colon Rectum; 1999 Mar; 42(3):386-92. PubMed ID: 10223762
[TBL] [Abstract][Full Text] [Related]
18. [Computer study of pathologic factors influencing survival in colorectal carcinoma--a multivariant stepwise discriminant analysis].
Zhou W
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):354-6. PubMed ID: 2177397
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
20. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
